HELICOBACTER PYLORI - IgG (ELFA)

Bacterial/ Viral

Report in 48Hrs

At Home

No Fasting Required

Details

Detects the presence of IgA antibodies against H. pylori bacteria in the blood using the CLIA method

₹850₹2,500

66% OFF

HELICOBACTER PYLORI - IgG (ELFA) Test Information Guide

Why is it done?
- Detects IgG antibodies against Helicobacter pylori bacteria to determine current or past infection status
- Primary indications for ordering:
  - Evaluation of chronic or recurrent peptic ulcer disease
  - Investigation of chronic gastritis or dyspepsia symptoms
  - Screening in areas with high H. pylori prevalence
  - Risk stratification for gastric cancer in high-risk populations
  - Family history of H. pylori infection or gastric malignancy
- Typical timing and circumstances:
  - Initial serology testing when H. pylori infection is suspected
  - Can be performed at any time and does not require active infection to detect antibodies
  - Particularly useful in asymptomatic individuals or when urea breath test is not available
Normal Range
- Reference Values:
  - Negative: < 0.9 Index or < 10 mIU/mL (laboratory-dependent)
  - Borderline/Equivocal: 0.9 - 1.1 Index (may require repeat testing or confirmation)
  - Positive: > 1.1 Index or > 10 mIU/mL (indicates presence of H. pylori antibodies)
- Units of Measurement:
  - Index value (optical density ratio) or mIU/mL (milli-International Units per milliliter)
  - ELFA (Enzyme-Linked Fluorescence Assay) methodology provides quantitative results
- Interpretation Guide:
  - Negative Result (Normal): Indicates absence of H. pylori antibodies; unlikely to have current or recent H. pylori infection; however, does not completely exclude very recent infection (window period before antibody formation)
  - Positive Result (Abnormal): Indicates presence of H. pylori IgG antibodies, suggesting current or past infection; may indicate active infection or past exposure; requires clinical correlation with symptoms and additional confirmatory testing if first positive result
  - Borderline Result: Requires repeat testing or alternative confirmation methods due to technical or biological variables
Interpretation
- Detailed Result Interpretation:
  - Positive IgG Result:
    - Indicates H. pylori infection at some point; IgG antibodies persist for years even after successful eradication
    - Cannot differentiate between active infection and past exposure without additional testing (IgM or IgA serology, stool antigen, urea breath test, or biopsy)
    - Higher index values (significantly elevated) may suggest more recent or active infection
  - Negative IgG Result:
    - Suggests no prior or current H. pylori infection
    - Very recent infection may produce false negative result (window period, typically 1-2 weeks)
    - May need repeat testing if high clinical suspicion exists
- Factors Affecting Results:
  - Recent proton pump inhibitor (PPI) use: May suppress antibody levels but does not eliminate seropositivity
  - Recent antibiotic therapy: May affect bacterial load but does not eliminate antibodies
  - Time since infection: IgG persists indefinitely after successful treatment
  - Immunosuppression: May result in false negative results due to impaired antibody production
  - Cross-reactivity: Other Helicobacter species may cause false positive results in rare cases
- Clinical Significance of Result Patterns:
  - Symptomatic Patient + Positive IgG: Warrants further investigation; consider confirmatory testing to determine if infection is active
  - Asymptomatic Patient + Positive IgG: May indicate past infection; eradication therapy generally recommended only if high-risk for complications
  - Post-Treatment Monitoring + Still Positive IgG: Expected finding; IgG remains positive for years after successful eradication
  - Symptomatic Patient + Negative IgG: Effectively rules out H. pylori infection in most cases; consider other differential diagnoses
Associated Organs
- Primary Organ System:
  - Gastrointestinal tract, specifically the stomach and duodenum
  - Gastric mucosa colonization by H. pylori leads to chronic inflammation
- Medical Conditions Associated with H. pylori Infection:
  - Peptic ulcer disease (duodenal and gastric ulcers): H. pylori causes approximately 90% of duodenal ulcers and 70% of gastric ulcers
  - Chronic gastritis: Persistent inflammation of gastric mucosa, leading to atrophy and achlorhydria
  - Gastric cancer (adenocarcinoma): H. pylori is a Class 1 carcinogen; increases risk of intestinal-type gastric cancer
  - Gastric mucosa-associated lymphoid tissue (MALT) lymphoma: H. pylori-associated low-grade lymphoma
  - Functional dyspepsia: Association remains under investigation
  - Intestinal metaplasia: Precancerous condition of gastric mucosa
- Diseases This Test Helps Diagnose:
  - Active H. pylori infection: Positive IgG with supporting clinical features and confirmatory tests
  - Past or latent H. pylori infection: Positive IgG alone
  - Rules out H. pylori etiology of peptic ulcer disease or dyspepsia when negative
- Potential Complications Associated with Abnormal Results:
  - Hemorrhage from ulcer erosion into blood vessels
  - Perforation of gastric or duodenal wall leading to peritonitis
  - Gastric outlet obstruction from scarring
  - Progression to gastric cancer over decades of untreated infection
  - MALT lymphoma transformation
Follow-up Tests
- Confirmatory Tests for Positive IgG Results:
  - Urea Breath Test (UBT): Non-invasive, detects active infection; preferred confirmatory test
  - H. pylori Stool Antigen Test: Detects active infection; can be used for diagnosis and post-treatment confirmation
  - H. pylori Culture or PCR from Gastric Biopsy: Gold standard for diagnosis when endoscopy performed; allows antimicrobial susceptibility testing
  - H. pylori IgA and IgM Serology: May provide information about infection recency when combined with IgG
- Recommended Additional Tests Based on Clinical Presentation:
  - Upper Endoscopy (Esophagogastroduodenoscopy or EGD): For symptomatic patients; allows direct visualization and biopsy for histology and culture
  - Rapid Urease Test (RUT) on Endoscopic Biopsies: Quick detection of urease-producing H. pylori
  - Gastric Biopsy Histopathology: Gold standard for diagnosing H. pylori gastritis and detecting atrophy, metaplasia, or dysplasia
  - Serum Pepsinogen I and II Levels: Assess gastric mucosal atrophy in chronic H. pylori infection
  - Complete Blood Count (CBC): May show anemia from chronic GI bleeding
- Monitoring After Treatment:
  - Post-treatment confirmation (4 weeks after completing therapy): Urea breath test, stool antigen test, or endoscopic biopsy preferred over serology
  - H. pylori IgG will remain positive indefinitely after successful eradication; do not use for post-treatment assessment
  - Annual surveillance endoscopy may be considered for patients with extensive gastric atrophy or intestinal metaplasia
- Related Tests Providing Complementary Information:
  - Gastrin Level: Elevated in achlorhydria secondary to H. pylori-induced atrophy
  - H. pylori Resistance Testing (if available): May guide eradication therapy selection in difficult-to-treat cases
Fasting Required?
- Fasting Status:
  - NO fasting is required for H. pylori IgG serology (ELFA)
  - Blood sample can be collected at any time of day
- Medications to Avoid or Consider:
  - Proton Pump Inhibitors (omeprazole, lansoprazole, pantoprazole, etc.): Discontinue 2 weeks prior to testing if possible; they may suppress IgG levels without eliminating seropositivity
  - H2-receptor antagonists (ranitidine, famotidine): May slightly affect results; discontinue 2 weeks prior if feasible
  - Antibiotics: Discontinue at least 4 weeks prior to testing to allow for accurate serological results
  - Note: Discuss with physician if discontinuing medications may harm the patient
- Other Patient Preparation Requirements:
  - No special preparation needed; routine venipuncture technique for serum blood collection
  - Serum sample (no anticoagulant): Blood collected in serum separator tube (SST) or plain tube
  - Allow blood to clot and centrifuge according to laboratory protocol
  - No specific patient positioning or preparation required
  - Notify healthcare provider of any recent medications or supplements

How our test process works!